Search research articles
Contact Us
Filters
Showing results (1-10 of 15) with videos related to
Page
of 2
Sort By:
Contemporary Clinical Trials Communications
|
April 3, 2023
Interactive statistical monitoring to optimize review of potential clinical trial issues during study conduct
David Pau, Marie Lotz, Gaëlle Grandclaude, et al.
PLOS Digital Health
|
February 3, 2025
Comparison of anonymization techniques regarding statistical reproducibility
David Pau, Camille Bachot, Charles Monteil, et al.
Plos One
|
November 14, 2024
Capability and accuracy of usual statistical analyses in a real-world setting using a federated approach
Romain Jégou, Camille Bachot, Charles Monteil, et al.
Nephrologie & Therapeutique
|
April 10, 2019
"Doctor, can I have less frequent injection with highly efficient treatment?" A patient centered study using an electronic choice-based conjoint analysis (ePRO) to assess real world preferences regarding erythropoiesis stimulating agent to treat anaemia in chronic kidney disease (PERCEPOLIS study)
Cécile Vigneau, Gabriel Choukroun, Corinne Isnard-Bagnis, et al.
Nephrologie & Therapeutique
|
March 26, 2019
[Impact of comorbidities on hemoglobin stability in patients with chronic kidney insufficiency on hemodialysis, treated with CERA in current practice: The MIRIADE study]
Luc Frimat, Mustapha Amirou, Jean-Paul Jaulin, et al.
Lung Cancer (Amsterdam, Netherlands)
|
December 26, 2021
FRESC: French Real world Extensive stage SCLC Cohorts: A retrospective study on patient characteristics and treatment strategy based on KBP-2010
Didier Debieuvre, Charles Dayen, Adrien Dixmier, et al.
Multiple Sclerosis and Related Disorders
|
June 11, 2026
Validation and psychometric properties of the Multiple Sclerosis Autonomy Score (MSAS) in a French cohort: The FOCAL-MS 2 study
Cécile Donzé, Claude Mekies, Catherine Mouzawak, et al.
Contemporary Clinical Trials
|
December 31, 2017
A multidisciplinary approach to oncology trials: Study conduct of the ANTHALYA trial
Youssef Ghazi, Christine Laurent, Julien Dupin, et al.
Plos One
|
April 16, 2026
Epidemiology and care management of Paroxysmal Nocturnal Hemoglobinuria (PNH) in a real-world setting in France: Description from the French National Hospitalization Database
Régis Peffault de Latour, Sophie Pibre, Julien Vercruyssen, et al.
Multiple Sclerosis and Related Disorders
|
October 18, 2024
Development of a new patient-reported outcome measure for patients with multiple sclerosis: the Multiple Sclerosis Autonomy Scale (MSAS)
Cécile Donzé, Claude Mekies, Géraud Paillot, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 15) with videos related to
Sort By:
Page
of 2
Contemporary Clinical Trials Communications
|
April 3, 2023
Interactive statistical monitoring to optimize review of potential clinical trial issues during study conduct
David Pau, Marie Lotz, Gaëlle Grandclaude, et al.
PLOS Digital Health
|
February 3, 2025
Comparison of anonymization techniques regarding statistical reproducibility
David Pau, Camille Bachot, Charles Monteil, et al.
Plos One
|
November 14, 2024
Capability and accuracy of usual statistical analyses in a real-world setting using a federated approach
Romain Jégou, Camille Bachot, Charles Monteil, et al.
Nephrologie & Therapeutique
|
April 10, 2019
"Doctor, can I have less frequent injection with highly efficient treatment?" A patient centered study using an electronic choice-based conjoint analysis (ePRO) to assess real world preferences regarding erythropoiesis stimulating agent to treat anaemia in chronic kidney disease (PERCEPOLIS study)
Cécile Vigneau, Gabriel Choukroun, Corinne Isnard-Bagnis, et al.
Nephrologie & Therapeutique
|
March 26, 2019
[Impact of comorbidities on hemoglobin stability in patients with chronic kidney insufficiency on hemodialysis, treated with CERA in current practice: The MIRIADE study]
Luc Frimat, Mustapha Amirou, Jean-Paul Jaulin, et al.
Lung Cancer (Amsterdam, Netherlands)
|
December 26, 2021
FRESC: French Real world Extensive stage SCLC Cohorts: A retrospective study on patient characteristics and treatment strategy based on KBP-2010
Didier Debieuvre, Charles Dayen, Adrien Dixmier, et al.
Multiple Sclerosis and Related Disorders
|
June 11, 2026
Validation and psychometric properties of the Multiple Sclerosis Autonomy Score (MSAS) in a French cohort: The FOCAL-MS 2 study
Cécile Donzé, Claude Mekies, Catherine Mouzawak, et al.
Contemporary Clinical Trials
|
December 31, 2017
A multidisciplinary approach to oncology trials: Study conduct of the ANTHALYA trial
Youssef Ghazi, Christine Laurent, Julien Dupin, et al.
Plos One
|
April 16, 2026
Epidemiology and care management of Paroxysmal Nocturnal Hemoglobinuria (PNH) in a real-world setting in France: Description from the French National Hospitalization Database
Régis Peffault de Latour, Sophie Pibre, Julien Vercruyssen, et al.
Multiple Sclerosis and Related Disorders
|
October 18, 2024
Development of a new patient-reported outcome measure for patients with multiple sclerosis: the Multiple Sclerosis Autonomy Scale (MSAS)
Cécile Donzé, Claude Mekies, Géraud Paillot, et al.
Page
of 2